Table 2 Pathogens isolated from device–associated infections during 2000–2008
Isolated pathogens | Ventilator–associated pneumonia | Central line–associated bloodstream infection | Catheter–associated urinary tract infection |
|---|---|---|---|
(%)(n = 500) | (%)(n = 323) | (%)(n = 467) | |
Gram–positive cocci | 18.0 | 30.2 | 15.9 |
Staphylococcus aureus | 17.4* | 20.4* | 2.6 |
coagulase–negative staphylococcus | 0 | 4.6 | 1.5 |
Enterococcus sp. | 0 | 3.4 | 10.5* |
others | 0 | 1.5 | 0.4 |
Gram–positive bacilli | 0.6 | 0.3 | 0.9 |
Gram–negative bacilli | 79.6 | 44.7 | 48.2 |
Enterobacteriaceae | 14.6 | 11.8 | 25.3 |
Escherichia Coli | 2.4 | 2.8 | 9.9* |
Klebsiella pneumoniae | 9.4 | 5.0 | 9.2 |
Proteus Mirabilis | 0.2 | 0.3 | 2.6 |
Serratia marcescens | 1.0 | 3.7 | 1.7 |
Enterobacter sp. | 1.6 | 0 | 1.9 |
non fermentative Gram negative bacilli | 62.2 | 27.3 | 19.9 |
Pseudomonas aeruginosa | 18.2* | 5.6 | 8.8 |
Acinetobacter baumannii | 23.0* | 14.9* | 6.9 |
Burkholderia cepacia | 4.8 | 2.2 | 1.3 |
Stenotrophomonas maltophilia | 12.4 | 3.1 | 1.3 |
others | 3.8 | 1.5 | 1.7 |
other Gram–negative bacilli | 2.8 | 5.5 | 2.9 |
Yeast | 2.4 | 25.1 | 35.9 |
Candida Albicans | 0.2 | 14.6* | 4.9 |
non–albicans Candida spp. | 0.2 | 6.2 | 3.4 |
others | 2.0 | 4.3 | 27.6* |